about
The diabetic lung--a new target organ?Diabetic Microvascular Disease and Pulmonary Fibrosis: The Contribution of Platelets and Systemic InflammationThe association of normal range glycated hemoglobin with restrictive lung pattern in the general populationVisit-to-visit glycemic variability is a strong predictor of chronic obstructive pulmonary disease in patients with type 2 diabetes mellitus: Competing risk analysis using a national cohort from the Taiwan diabetes study.Type 2 diabetes is associated with an increased prevalence of respiratory symptoms as compared to the general population.Aerobic exercise capacity and pulmonary function in athletes with and without type 1 diabetes.Pulmonary functions in patients with diabetes mellitusExtreme values of hemoglobin a1c are associated with increased risks of chronic obstructive pulmonary disease in patients with type 2 diabetes: a competing risk analysis in national cohort of Taiwan diabetes study.Common and rare exonic MUC5B variants associated with type 2 diabetes in Han Chinese.Effects of smoking cessation, acute re-exposure and nicotine replacement in smokers on AIR inhaled insulin pharmacokinetics and glucodynamics.Inhaled human insulin (Exubera(®)): its pharmacologic profile, efficacy and safety in the treatment of adults with diabetes mellitus.Global Autorecognition and Activation of Complement by Mannan-Binding Lectin in a Mouse Model of Type 1 Diabetes.Lung alterations in a rat model of diabetes mellitus: effects of antioxidant therapy.Pharmacokinetics and pharmacodynamics of inhaled GLP-1 (MKC253): proof-of-concept studies in healthy normal volunteers and in patients with type 2 diabetes.Experimental diabetes mellitus: oxidative stress and changes in lung structure.Genistein preserves the lungs of ovariectomized diabetic rats: addition to apoptotic and inflammatory markers in the lung.Long-term effect of insulin treatment in cystic fibrosis-related diabetes.Hypoxia-induced acute lung injury is aggravated in streptozotocin diabetic mice.Pulmonary Function Difference in Sasang Constitutional Types.
P2860
Q27027639-0BCCF2A4-B1BD-42CB-A8A6-A2AEA5720413Q28073977-C1048CD1-803F-4DE8-BB6C-899CEDEA6930Q28543247-BB97FBEF-C7B1-4677-8533-D6E065FAF08EQ33657819-5ED533BB-9794-4D9A-9EA7-3ED3D51D7EE5Q33910703-A427DD37-6AE1-4A2D-9B21-7DCA8686A514Q34351721-8DC5E295-0C21-4C08-87E0-A3E0CFACA73DQ35030294-380FB53F-92A6-4CFD-9ED6-3C1977A46C03Q36152781-867865C7-600D-4051-9717-56664872118EQ36323726-C09A163C-5661-447E-B17F-63109347BAEDQ36536435-01971703-BD52-405A-85A6-A22B9C34C5A2Q40138501-9BF39CD8-5145-4FD9-B3CF-7035F30A8D2BQ41038156-D6C9B3A7-6EE6-4249-B8E7-C13C3147D4D5Q42803443-39360932-59B7-4442-A1A7-43E1F6514749Q42997344-722F5926-65F9-4217-9512-644AE1520F00Q43277236-5BF72F2C-1809-4CD5-8D7E-9735033D5525Q47102209-D1C3E5D7-390B-42E9-A72E-3CAEFD6A801AQ51108957-982B4413-A81C-42B1-A890-838071616E14Q51674482-5260BAD3-55BC-4DB7-A910-72B455667035Q54957871-E9BB14A1-2E0A-413D-B2E8-103D96AC8C52
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Lung dysfunction in diabetes.
@ast
Lung dysfunction in diabetes.
@en
type
label
Lung dysfunction in diabetes.
@ast
Lung dysfunction in diabetes.
@en
prefLabel
Lung dysfunction in diabetes.
@ast
Lung dysfunction in diabetes.
@en
P1433
P1476
Lung dysfunction in diabetes.
@en
P2093
Michael David Goldman
P304
P356
10.2337/DIACARE.26.6.1915
P407
P577
2003-06-01T00:00:00Z